COVID-19 rapid test CoVAgLFA-01

for antigensvirusnasopharyngeal

The COVID-19 Antigen Lateral Flow Assay is a lateral flow immunoassay intend for the qualitative detection SARS-CoV-2 nucleocapsid protein antigens in nasopharyngeal swab and oropharyngeal swab from individuals who are suspected of COVID-19 by their healthcare provider. Equipped with most consumables needed, it is rapid, accurate, cost-effective and user-friendly. Characteristics Specification 20 tests/kit Stability The kit is stable for 1 year at 2-30°C Advantage Intuitive result There is no need for calculation, visual reading result Economic Product can be transported and stored at room temperature, reducing costs